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A B S T R A C T
A total of 835 patients with symptoms of chronic prostatitis syndrome and no evidence of structural or functional
lower genitourinary tract abnormalities were examined in a three year period at the Outpatient Department for Urogeni-
tal Infections, University Hospital for Infectious Diseases »Dr Fran Mihaljevi}« Zagreb, Croatia. Disease etiology was
determined in 482 (57.72%) patients. Chlamydia trachomatis was proved to be the causative pathogen in 161 patients,
Trichomonas vaginalis in 85, Escherichia coli in 68, Enterococcus in 51, Proteus mirabilis in 20, Klebsiella pneumoniae
in 9, Streptococcus agalactiae in 15, Ureaplasma urealyticum in 49 patients with chronic prostatitis. Other patients had
mixed infection. In 257 (53.32%) of 482 patients, the inflammatory finding (>10 WBCs/hpf) was found in EPS or VB3.
Normal WBCs/hpf (<10) was found in 103 (63.98%) of 161 patients with symptoms of chronic prostatitis in whom C.
trachomatiswas detected in EPS or VB3, in 50 (58.82%) of 85 patients in whom Trichomonas vaginaliswas isolated, and
in 23 (46.94%) of 49 patients in whom Ureaplasma urealyticum was isolated.
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Introduction
The term prostatitis syndrome refers to a number of
conditions affecting the prostate and is clinically pre-
sented with:
1. urethral symptoms (frequency, difficult and urgent
urination, burning in the urethra during voiding, thin in-
terrupted voided urine, urethral discharge, prostator-
rhea, leukocytospermia),
2. prostatic symptoms (pressure, tension or pain in
perineum, groins, lower abdomen and back, testes and
epididymes),
3. sexual dysfunction (erectile dysfunction, ejacula-
tory dysfunction, loss of libido),
4. other symptoms (fatigue, myalgia, headache etc.)1,2.
Basic factors for the classification of prostatitis syn-
drome are clinical symptoms and signs and the presence of
bacteria and leukocytes in selectively collected urine sam-
ples (first voided urine – VB1, midstream urine – VB2, urine
collected immediately after prostatic massage – VB3) and in
expressed prostatic secretion (EPS) by Meares and Stamey
localization technique3. Generally accepted classification of
prostatitis syndrome differentiates between:
1. acute bacterial prostatitis,
2. chronic bacterial prostatitis,
3. nonbacterial prostatitis,
4. prostatodynia4
In December 1995, a new classification system of pro-
statitis syndrome has been introduced in the USA:
1. acute bacterial prostatitis (ABP) – acute infection
of the prostate,
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2. chronic bacterial prostatitis (CBP) – recurrent in-
fection of the prostate,
3. chronic pelvic pain syndrome (CPPS) – no demon-
strable infection,
3a. inflammatory CPPS – chronic abacterial prostatitis
– white cells in expressed prostatic secretions / voided blad-
der urine3 (VB3),
3b. non-inflammatory CPPS – no white cells in EPS
/VB3,
4. asymptomatic inflammatory prostatitis (AIP) – no
subjective symptoms detected either by prostate biopsy
or the presence of white blood cells (WBC) in prostate se-
cretions during evaluation for other disorders5.
Symptoms, clinical signs and microscopic finding of
expressed prostatic secretion during inflammatory chro-
nic pelvic pain syndrome with no demonstrable infection
and chronic bacterial prostatitis are not different6. Chro-
nic bacterial prostatitis is the most common cause of re-
lapsing urinary tract infection in men. It is manifested by
longer asymptomatic period between episodes of recur-
rent bacteriuria. Pathogens of chronic bacterial prostati-
tis are also causing other urinary tract infections. Pati-
ents with inflammatory chronic pelvic pain syndrome –
no demonstrable infection – have no history of previously
diagnosed urinary infection, and bacteriological analysis
of urine sample and EPS by standard methods cannot
prove the infectious nature of the disease. Controversy
regarding the role of chlamydia, ureaplasma, and myco-
plasma in the pathogenesis of prostatitis continues7–10.
Therefore, Chlamydia trachomatis, Ureaplasma urealy-
ticum, Mycoplasma hominis and Trichomonas vaginalis
findings in EPS of some patients cannot be ignored11–18.
The aim of this prospective study was to investigate
the etiology and the role of unusual pathogens in chronic
prostatitis syndrome (bacterial prostatitis, inflammatory
as well as noninflammatory chronic pelvic pain syndrome).
Patients and Methods
The study was conducted at the Outpatient Depart-
ment for Urogenital Infections, University Hospital for
Infectious Diseases »Dr Fran Mihaljevi}« Zagreb, Croatia,
between January 1, 2003 and December 31, 2005. The
Ethics Committee of the hospital approved the study.
Patients
We examined a total of 835 patients, older than 18
years of age, with symptoms of chronic prostatitis syn-
drome (bacterial prostatitis, inflammatory as well as no-
ninflammatory chronic pelvic pain syndrome) and no evi-
dence of structural or functional lower genitourinary
tract abnormalities, of urethritis or urethral pathogens
by culture.
Diagnostic criteria
The inclusion criteria for chronic prostatitis syndrome
was the duration of symptoms for at least three months.
The inclusion criteria for chronic bacterial prostatitis
were:
– presence of clinical symptoms
– a bacterial count of 103 cfu/ml or more (if only
Gram-positive cocci are found in EPS, a bacterial
count of 104 cfu/ml or more is required), and 10 or
more WBCs/hpf (including macrophages) in EPS or
VB3
, or
– finding of 10 or many times greater number of bac-
teria in EPS and urine bladder sample collected im-
mediately after prostatic massage, than in first
voided urine or midstream urine, and
– presence of 10 or more WBCs/hpf in EPS or VB3.
The inclusion criteria for chronic prostatitis caused by
C. trachomatis were:
– presence of clinical symptoms,
– presence of C. trachomatis in EPS or VB3
– absence of C. trachomatis in urethral swabs
– absence of other possible pathogens of chronic pros-
tatitis in urethral swabs, EPS or VB3.
The inclusion criteria for chronic prostatitis caused by
Ureaplasma urealyticum or Mycoplasma hominis were:
– presence of clinical symptoms
– presence of U. urealyticum or M. hominis in EPS or
VB3,
– absence of U. urealyticum or M. hominis in urethral
swabs
– absence of other possible pathogens of chronic pros-
tatitis in urethral swabs, EPS or VB3.
The inclusion criteria for chronic prostatitis caused by
T. vaginalis were
– presence of clinical symptoms
– presence of T. vaginalis in EPS or VB3
– absence of T. vaginalis in urethral swabs
– absence of other possible pathogens of chronic pros-
tatitis in urethral swabs, EPS or VB3.
The inclusion criteria for nonbacterial prostatitis or
inflammatory chronic pelvic pain syndrome were
– presence of clinical symptoms
– presence of ten or more WBC/hpf in EPS or VB3
– presence of other possible nonbacterial pathogens
in EPS or VB3
– absence of possible bacterial pathogens of chronic
prostatitis in urethral swabs, EPS or VB3.
The inclusion criteria for non-inflammatory chronic
pelvic pain syndrome were
– presence of clinical symptoms of prostatitis syn-
drome
– no white cells in EPS or VB3
– absence of possible pathogens of chronic prostatitis
in urethral swabs, EPS or VB3.
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Methods
The following data were obtained for each patient:
anamnesis, clinical status including digitorectal prostatic
examination, urethral swab specimen and selective sam-
ples of urine and EPS, according to the 4-glass localiza-
tion test.
Urethral swab specimens were analyzed for Chla-
mydia trachomatis, Trichomonas vaginalis, Ureaplasma
urealyticum and Mycoplasma hominis. In segmented
samples of urine (VB1, VB2, VB3) and EPS we determined
the number of leukocytes and the number of Gram-posi-
tive and Gram-negative bacteria in 1 ml of sample.
EPS and urine sample collected immediately after
prostatic massage were analyzed for the presence of
Chlamydia trachomatis, Ureaplasma urealyticum, Myco-
plasma hominis and Trichomonas vaginalis.
Quantitative segmented cultures and bacterial identi-
fication in three voided urine samples and EPS as well as
bacteriological analysis of urethral swabs were perfor-
med at the Laboratory for Clinical Microbiology of the
University Hospital for Infectious Diseases »Dr. Fran Mi-
haljevi}«, Zagreb, Croatia, with standard microbiological
methods. The diagnosis of urogenital mycoplasma was
confirmed by semiquantitative culturing and antimic-
robial susceptibility test Mycoplasma duo and S.I.R My-
coplasma test (Bio Rad Laboratories). The diagnosis of
Trichomonas vaginalis was confirmed by culturing on
DIAMOND modified medium. Chlamydia trachomatis
was proved in urethral swabs / EPS / urine sample collec-
ted immediately after prostatic massage, by isolation on
McCoy cells and immunofluorescent typing with mono-
clonal antibodies (Croatian Institute for Public Health,
Zagreb, Croatia) or by DNA/RNA hybridization method
(hospital's laboratory).
Results
In our study an infectious etiology in patients with
chronic prostatitis syndrome was determined in 482
(57.72%) patients (Table 1.). The analysis of the etiology
of chronic prostatitis syndrome in 835 patients showed
that Chlamydia trachomatis, Trichomonas vaginalis and
Ureaplasma urealyticum were the causative pathogens
in one third (295/835 – 35.33%) of our patients with chro-
nic prostatitis syndrome. In 257 (53.32%) of 482 patients,
the inflammatory finding (>10 WBCs/hpf) was found in
EPS or VB3. Normal WBCs/hpf (<10) was found in 103
(63,98%) of 161 patients with symptoms of chronic pros-
tatitis in whom C. trachomatis was detected in EPS or
VB3, in 50 (58,82%) of 85 patients in whom Trichomonas
vaginalis was isolated, and in 23 (46,94%) of 49 patients
in whom Ureaplasma urealyticum was isolated.
In 113 (76.35%) of 148 patients in whom E.coli, Ente-
rococcus, P. mirabilis or Klebsiella pneumoniae were de-
tected in EPS or VB3, the inflammatory finding (>10
WBCs/hpf) was found in EPS or VB3.
In 10 (66.67%) of 15 patients in whom Streptococcus
agalactiae was isolated in EPS or VB3, the inflammatory
finding (>10 WBCs/hpf) was found in EPS or VB3.
Discussion and Conclusion
Pathogens of bacterial prostatits also cause urinary
infections1,2. These are Escherichia coli, Klebsiella pneu-
moniae, Morganella spp, Enterococcus spp and signifi-
cantly rare Pseudomonas aeruginosa. Prostatitis patho-
gens are bacteria capable of replicating in prostate,
causing relapsing urinary tract infections and can be de-
tected in expressed prostatic excretion. Therefore, it is
questionable whether coagulase negative staphylococci,
Staphylococcus aureus, micrococci, streptococcus outside
group D and diphtheroids, can be considered pathogens
of bacterial prostatitis1,2,6. Of special interest is to clarify
the etiological meaning of group B streptococcus19. Strep-
tococcus agalactiae often colonizes vagina, and causes
urinary tract infections and perinatal complications.
Men can acquire Streptococcus agalactiae from their par-
tners and vice versa. Staphylococcus aureus is also de-
scribed as pathogen causing hospital acquired prostatitis
in patients with permanent urinary catheter20. Several
patients with prostatitis were described in whom Staphy-
lococcus epidermidis eradication from EPS was accompa-
nied by significantly reduced clinical symptoms and with
disappearance of polimorphonuclear leukocytes from
EPS21.
In the 835 analyzed patients with etiologically proved
chronic prostatitis, Escherichia coli was detected in 68
(8.14%) of patients, Enterococcus in 51 (6.11%) Proteus
mirabilis or Klebsiella pneumoniae in 29 (3.48%), and
Streptococcus agalactiae in 15 (1.80%), while 23 (2.75%)
patients had mixed infection.
Chlamydia trachomatis is a Gram-negative intracel-
lular bacterium with special lifecycle of development and
growth. It is the most common bacterial pathogen caus-
ing sexually transmitted diseases and the most frequent
cause of epididymitis in patients up to 35 years of age22,23.
More than half of the infected persons have asymptom-
atic form of infection or very mild clinical course, which
is one of the reasons for its non recognition and untreat-
ment thus leading Chlamydia trachomatis to be the con-
stant source of infection among general population25.
Chlamydia trachomatis was proved to be the only ca-
usative agent of prostatitis syndrome in 161 (19.38%) pa-
tients with etiologically proved chronic prostatitis syn-
drome. We believe that the role of Chlamydia trachomatis
in chronic prostatitis has been underestimated so far. Sin-
ce Chlamydia trachomatis is a bacterium, chlamydial
prostatitis should be classified as chronic bacterial pros-
tatitis as was suggested by other authors as well26.
It is significant that Trichomonas vaginalis was the
causative pathogen in 85 patients, which makes 10.18%
of patients with etiologically proved chronic prostatitis,
and Ureaplasma urealyticum in 49 (5.87%) patients. In
257 (53.32%) of 482 patients, the inflammatory finding
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(>10 WBCs/hpf) was found in EPS or VB3. Normal
WBCs/hpf (<10) was found in 103 (63.98%) of 161 pa-
tients with symptoms of chronic prostatitis in whom C.
trachomatis was detected in EPS or VB3, in 50 (58.82%)
of 85 patients in whom Trichomonas vaginalis was iso-
lated, and in 23 (46.94%) of 49 patients in whom Urea-
plasma urealyticum was isolated.
The authors hope that the results of this study on
chronic prostatitis syndrome pathogens as well as the re-
sults of our previous studies will contribute to further
clarification of etiology of chronic bacterial prostatitis
and inflammatory chronic pelvis pain syndrome and help
in determining the empirical antimicrobial therapy27,28.
We believe it would be interesting to investigate the
causative pathogens of prostatitis syndrome in HIV/AIDS
patients since the causes of urinary tract infections in
these patients are different from those in patients who
are not infected with HIV.29
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TABLE 1
THE ETIOLOGY OF CHRONIC PROSTATITIS SYNDROME IN PATIENTS TREATED AT THE UNIVERSITY HOSPITAL FOR INFECTIOUS
DISEASES »DR. FRAN MIHALJEVI]« FROM 2003 TO 2005
Microorganism confirmed
in EPS or VB3
Patients
> 10 WBCs/hpf in EPS (no.) < 10 WBCs/hpf in EPS (no.) Total no. (%)
Chlamydia trachomatis 58 103 161 (19.28)
Trichomonas vaginalis 35 50 85 (10.18)
Ureaplasma urealyticum 26 23 49 (5.87)
Escherichia coli 53 15 68 (8.14)
Enterococcus 38 13 51 (6.11)
Proteus mirabilis 15 5 20 (2.40)
Klebsiella pneumoniae 7 2 9 (1.08)
Streptococcus agalactiae 10 5 15 (1.80)
Pseudomonas aeruginosa 0 1 1 (0.12)
Mixed infection 15 8 23 (2.75)
None 241 112 353 (42.28)
Total 498 337 835 (100)
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ETIOLOGIJA SINDROMA KRONI^NOG PROSTATITISA U BOLESNIKA LIJE^ENIH U
KLINICI ZA INFEKTIVNE BOLESTI »DR. FRAN MIHALJEVI]«, ZAGREB U RAZDOBLJU
OD 2003. DO 2005. GODINE
S A @ E T A K
Ukupno je 835 bolesnika sa simptomima sindroma kroni~nog prostatitisa i bez dokazanih strukturalnih ili funk-
cionalnih abnormalnosti donjeg genitourinarnog sustava pregledano u trogodi{njem razdoblju u Ambulanti za uro-
genitalne infekcije Klinike za infektivne bolesti »Dr. Fran Mihaljevi}«, Zagreb. Etiologija bolesti dokazana je u 482
(57,72%) bolesnika. Chlamydia trachomatis je dokazana kao uzro~nik bolesti u 161 bolesnika, Trichomonas vaginalis u
85, Escherichia coli u 68, Enterococcus u 51, Proteus mirabilis u 20,Klebsiella pneumoniae u 9, Streptococcus agalactiae
u 15, te Ureaplasma urealyticum u 49 bolesnika. Ostali bolesnici su imali mije{anu infekciju. Ukupno 257 (53,32%) od
482 bolesnika imalo je upalni nalaz u EPS-u ili VB3. Normalan broj leukocita dokazan je u EPS-u ili VB3 u 103 (63,98%)
od ukupno 161 bolesnika sa simptomima kroni~nog prostatitisa u kojih je dokazana Chlamydia trachomatis, u 50 (58,82%)
od 85 bolesnika s izoliranom Trichomonas vaginalis, te u 23 (46,94%) od 49 bolesnika u kojih je izolirana Ureaplasma
urealyticum.
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